Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001521536-12-001212
Filing Date
2012-11-29
Accepted
2012-11-29 17:14:12
Documents
8

Document Format Files

Seq Description Document Type Size
1 q1100881_s1a-biozone.htm S-1/A 1793777
2 q1100881_ex23-1.htm EX-23.1 8282
  Complete submission text file 0001521536-12-001212.txt   5251926

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE FILE bzne-20120930.xml EX-101.INS 419977
4 XBRL SCHEMA FILE bzne-20120930.xsd EX-101.SCH 43281
5 XBRL CALCULATION FILE bzne-20120930_cal.xml EX-101.CAL 43616
6 XBRL DEFINITION FILE bzne-20120930_def.xml EX-101.DEF 190597
7 XBRL LABEL FILE bzne-20120930_lab.xml EX-101.LAB 226400
8 XBRL PRESENTATION FILE bzne-20120930_pre.xml EX-101.PRE 254464
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-176951 | Film No.: 121232536
SIC: 2834 Pharmaceutical Preparations